Cancel
Jessica Stitt
Chief Financial Officer
@
Sonoma BioTherapeutics
gu093x@uhpkf5p9l.wgv
Sign up to see email
Known information
- Holds an MBA from Simmons School of Management
- Earned a B.A. from Saint Anselm College
- Previously served as Chief Financial Officer at Gyroscope Therapeutics
- Worked as Vice President of Finance and Operations for MyoKardia, Inc.
- Served as Vice President of Finance and Investor Relations for Theravance Biopharma, Inc.
- Held roles in finance at Nektar Therapeutics, Alkermes, and Blue Cross Blue Shield of Massachusetts
About Sonoma BioTherapeutics
Sonoma BioTherapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell therapies for autoimmune and inflammatory diseases, with proprietary technologies and a new manufacturing facility in Seattle.
Report inaccurate information
